An AChE inhibitor
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Edrophonium (chloride)

Item No. 15928

Technical Information
Formal Name
N-ethyl-3-hydroxy-N,N-dimethyl-benzenaminium, monochloride
CAS Number
116-38-1
Molecular Formula
C10H16NO • Cl
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 0.5 mg/mlDMSO: 2 mg/mlEthanol: 10 mg/mlPBS (pH 7.2): 10 mg/ml
λmax
223, 277 nm
SMILES
OC1=CC([N+](C)(C)CC)=CC=C1.[Cl-]
InChi Code
InChI=1S/C10H15NO.ClH/c1-4-11(2,3)9-6-5-7-10(12)8-9;/h5-8H,4H2,1-3H3;1H
InChi Key
BXKDSDJJOVIHMX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Edrophonium (chloride) is an acetylcholinesterase (AChE) inhibitor that is known to prevent the breakdown of the neurotransmitter acetylcholine by binding specifically to its catalytic site.1 It has been shown to inhibit AChE activity in human red blood cells, purified calf forebrain, and purified octopus brain with Ki values of 0.2, 0.2, and 0.4 µM, respectively.2 Edrophonium is often used as part of a battery of pharmacological tests to confirm a diagnosis of the autoimmune neuromuscular junction disorder, myasthenia gravis.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Roufogalis, B.D., and Wickson, V.M. Acetylcholinesterase: Specificity of the peripheral anionic site for cholinergic ligands. Mol. Pharmacol. 11(3), 352-360 (2011).

    2. Boyle, N.A., Talesa, V., Giovannini, E., et alSynthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase. J. Med. Chem. 40(19), 3009-3013 (1997).

    3. Juel, V.C., and Massey, J.M. Myasthenia gravis. Orphanet J. Rare Dis. 2, 44 (2007).